Humana CMO granted 2,549 restricted shares

Humana’s chief medical officer received 2,549 restricted stock units under the 2026 Stock Incentive Plan, his only reported direct holdings after the grant.

Rhea-AI Filing Summary

HUMANA INC (symbol: HUM) is the issuer of record for a Form 4 filing submitted to the SEC. Nundy Shantanu reported acquisition or exercise transactions in this Form 4 filing.

HUMANA INC (HUM) reported that Chief Medical Officer Shantanu Nundy received an equity grant of 2,549 shares of Humana common stock on September 1, 2026. These are structured as restricted stock units, each representing a contingent right to one share under Humana’s 2026 Stock Incentive Plan, and are exempt under Rule 16b-3(d)(1)&(3). After this award, he holds 2,549 shares directly.

Insider Trade Summary

Grant/Award: 2,549 shares

Grant/Award 1 txn

Insider Nundy Shantanu

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Humana Common F1	2,549	$0.00	$0.00

Holdings After Transaction: Humana Common — 2,549 shares (Direct)

Footnotes (1)

1. F1. Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan.

Key Figures

Restricted stock units granted: 2,549 units Reported grant price per share: $0.00 per share Shares held after transaction: 2,549 shares

3 metrics

Restricted stock units granted 2,549 units Grant to Chief Medical Officer on September 1, 2026

Reported grant price per share $0.00 per share RSU grant of 2,549 Humana common shares

Shares held after transaction 2,549 shares Direct holdings of Chief Medical Officer after RSU grant

Key Terms

restricted stock units, contingent right, Rule 16b-3(d)(1)&(3), 2026 Stock Incentive Plan

4 terms

restricted stock units financial

"Includes 2,549 restricted stock units representing a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"restricted stock units representing a contingent right to receive one share"

Rule 16b-3(d)(1)&(3) regulatory

"exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026"

2026 Stock Incentive Plan financial

"under the Company's 2026 Stock Incentive Plan"

FAQ

What insider transaction did HUM (Humana Inc.) disclose for Shantanu Nundy?

Humana disclosed that Chief Medical Officer Shantanu Nundy received a grant of 2,549 restricted stock units of Humana common stock on September 1, 2026, reported as a grant or award acquisition with no cash price per share.

How many Humana (HUM) shares did the insider hold after the reported transaction?

After the September 1, 2026 grant, Chief Medical Officer Shantanu Nundy held 2,549 shares of Humana common stock directly, all represented by restricted stock units that give a contingent right to receive one share each.

Was the Humana (HUM) insider grant to Shantanu Nundy an open-market purchase?

No. The filing classifies the transaction as a grant, award, or other acquisition of 2,549 restricted stock units at a reported price of $0.00 per share, under Humana’s 2026 Stock Incentive Plan, not as an open-market purchase.

What type of equity was granted to Humana (HUM) Chief Medical Officer Shantanu Nundy?

He received 2,549 restricted stock units (RSUs), each representing a contingent right to receive one share of Humana Inc. common stock, granted under the company’s 2026 Stock Incentive Plan and reported as exempt under Rule 16b-3(d)(1)&(3).

Was a Rule 10b5-1 trading plan involved in the Humana (HUM) Form 4 for Shantanu Nundy?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the 2,549 restricted stock units grant to Chief Medical Officer Shantanu Nundy was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 01:33 PM Accepted by SEC EDGAR 09/03/2026 - 01:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nundy Shantanu

(Last) (First) (Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE KENTUCKY 40202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common	09/01/2026		A		2,549	A	$0	2,549(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan.

	Shantanu Nundy	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)